CAPSTONE THERAPEUTICS Corp/ US14068E2081 /
2023-11-17 9:10:20 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
7.0000USD | - | 448 Turnover: 700 |
-Bid Size: - | -Ask Size: - | 7.0000 | 4.9000 |
GlobeNewswire
2018-05-07
LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China
GlobeNewswire
2017-07-17
Capstone Therapeutics Announces Transaction for Sale of Shares of Its Common Stock and Secured Loan
GlobeNewswire
2016-12-19
Capstone Therapeutics Announces Profound, Rapid LDL Cholesterol Reduction in AEM-28-14 Primate Study